Our Customers
Products & Pipeline
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube
NHS
US Payers
next arrow
Back
News
1 Min Read

LTC News highlights how ieso’s recent research study benefits diabetes patients with depression

17 Jun 2022
By
ieso

LTC News have published a spotlight article on ieso’s latest study results. This comes a week after the announcement that the research study, conducted with support from Roche Diabetes Care Limited, shows online cognitive behavioural therapy benefits diabetes patients living with depression.

Patients who received online cognitive behavioural therapy, tailored for patients with Type 2 diabetes, reported improvements in depression and anxiety, which also led to better management of their diabetes diagnosis. Therefore, integrated mental health care in diabetes patients can significantly improve mental health outcomes, increase patient engagement in managing their condition, reduce distress levels about their diabetes, and better their quality of life.

It is estimated that comorbid physical and mental health conditions increase physical health care costs by 45% to 75%. Tailored interventions, however, are associated with substantial savings in health care costs, and continued advances in diabetes treatment, including addressing comorbidities like depression, will be of great benefit to patients.

Read the full article here: https://www.ltcnews.com/articles/online-cognitive-behavioral-therapy-benefiting-diabetes-patients-with-depression

ieso
LTC News have published a spotlight article on ieso’s latest study results. This comes a week after the announcement of ieso's research study, conducted with support from Roche Diabetes Care Limited.